What action did IFM Investors take against Atlas Arteria (ASX:ALX)?

IFM Investors filed an application with the Australian Takeovers Panel seeking urgent orders against Atlas Arteria. IFM wants the court to force the company to disclose more information regarding its Chicago Skyway assets and certain internal arrangements.

Why is the Chicago Skyway asset at the center of this dispute?

The dispute involves a "right of first offer" that Atlas Arteria granted to the Ontario Teachers’ Pension Plan Board on April 22. IFM alleges that Atlas Arteria failed to disclose this arrangement to the market for nine days, during which time IFM launched its takeover bid.

What specific "disclosure gaps" is IFM alleging against Atlas Arteria (ASX:ALX)?

IFM claims Atlas Arteria withheld critical details about potential asset sales and the specific terms of its agreements with the Ontario Teachers’ Pension Plan Board.

What is a "frustrating action" in the context of the Atlas Arteria takeover?

A frustrating action occurs when a target company's board takes steps to block a takeover bid without giving shareholders a chance to vote on it. IFM argues that Atlas Arteria’s undisclosed arrangements regarding the Chicago Skyway could constitute such an action.

How much of Atlas Arteria (ASX:ALX) does IFM Investors currently own?

IFM Investors currently holds a substantial 34.48% stake in Atlas Arteria. This large position gives them significant leverage as both a major shareholder and a potential acquirer.

IFM seeks Panel orders over Atlas Arteria disclosures

Written by Heidi Cuthbert Published May. 13 2026

IFM Investors has lodged an application with the Takeovers Panel, seeking urgent orders to compel Atlas Arteria (ASX:ALX) to rectify alleged disclosure gaps regarding its Chicago Skyway holdings.

The move follows claims that Atlas Arteria withheld critical information concerning a "right of first offer" granted to the Ontario Teachers’ Pension Plan Board just days prior to IFM’s off-market takeover bid.

IFM, which currently maintains a 34.48% stake in the toll-road operator, argues that the failure to disclose these arrangements—specifically amidst a recommendation for shareholders to reject the bid—constitutes a material deficiency and a potential "frustrating action".

While the Panel has acknowledged the application, a sitting member has yet to be appointed to determine whether formal proceedings will commence.

At the time of reporting, Atlas Arteria’s share price was $4.79.